These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Beta-blocker in secondary prevention of cardiovascular disease]. Sauer G Z Kardiol; 2003 Jan; 92(1):24-30. PubMed ID: 12545298 [TBL] [Abstract][Full Text] [Related]
24. Beta-blockers and heart failure. Cruickshank JM Indian Heart J; 2010; 62(2):101-10. PubMed ID: 21180298 [TBL] [Abstract][Full Text] [Related]
25. Beta-blockers in hypertensive and coronary heart disease. Goldstein S Arch Intern Med; 1996 Jun; 156(12):1267-76. PubMed ID: 8651834 [TBL] [Abstract][Full Text] [Related]
26. Using beta blockers after MI in the elderly. Danforth J; Ports TA Geriatrics; 1985 May; 40(5):75-7, 80, 85. PubMed ID: 2859233 [TBL] [Abstract][Full Text] [Related]
27. β-Blockers in hypertension: studies and meta-analyses over the years. Larochelle P; Tobe SW; Lacourcière Y Can J Cardiol; 2014 May; 30(5 Suppl):S16-22. PubMed ID: 24750978 [TBL] [Abstract][Full Text] [Related]
28. [Coronary disease and antihypertensive treatment with beta blockers in older patients]. Wikstrand J Cardiologia; 1984; 29(1-2):129-44. PubMed ID: 6152540 [No Abstract] [Full Text] [Related]
29. Atenolol as a comparator in outcome trials in hypertension: a correct choice in the past, but not for the future? Dahlöf B; Devereux RB; Kjeldsen SE; Lyle PA; Zhang Z; Edelman JM Blood Press; 2007; 16(1):6-12. PubMed ID: 17453746 [TBL] [Abstract][Full Text] [Related]
30. How should we manage heart failure developing in patients already treated with angiotensin-converting enzyme inhibitors and beta-blockers for hypertension, diabetes or coronary disease? Gustafsson F; Segura J; Ruilope LM J Hypertens; 2010 Aug; 28(8):1595-8. PubMed ID: 20613629 [TBL] [Abstract][Full Text] [Related]
31. Benefits of inpatient initiation of beta-blockers. Ventura HO Am Heart J; 2004 Dec; 148(6):944-50. PubMed ID: 15632876 [TBL] [Abstract][Full Text] [Related]
32. [Beta-adrenergic receptor blockers in clinical practice]. Czuriga I; Edes I Orv Hetil; 2004 Sep; 145(38):1951-60. PubMed ID: 15535106 [TBL] [Abstract][Full Text] [Related]
34. [Aerobic training guidelines in beta blocker therapy. An update]. Samitz G Wien Med Wochenschr; 1991; 141(18-19):399-405. PubMed ID: 1685605 [TBL] [Abstract][Full Text] [Related]
35. Current recommendations for the treatment of hypertension: are they still valid? Moser M J Hypertens Suppl; 2002 Feb; 20(1):S3-10. PubMed ID: 11996197 [TBL] [Abstract][Full Text] [Related]
36. [Pharmacology of beta blockers and their significance for therapy of hypertension]. Wehling M Herz; 2002 Aug; 27 Suppl 1():16-25. PubMed ID: 12229254 [TBL] [Abstract][Full Text] [Related]
37. Current status of β-blockers for the treatment of hypertension: an update. Chrysant SG; Chrysant GS Drugs Today (Barc); 2012 May; 48(5):353-66. PubMed ID: 22645723 [TBL] [Abstract][Full Text] [Related]
38. Misconceptions and Facts About Beta-Blockers. Argulian E; Bangalore S; Messerli FH Am J Med; 2019 Jul; 132(7):816-819. PubMed ID: 30817899 [TBL] [Abstract][Full Text] [Related]
39. Choosing the right beta-blocker. A guide to selection. Hampton JR Drugs; 1994 Oct; 48(4):549-68. PubMed ID: 7528129 [TBL] [Abstract][Full Text] [Related]
40. Antihypertensive and cardioprotective effects of three generations of beta-adrenergic blockers: an historical perspective. Chrysant SG; Chrysant GS Hosp Pract (1995); 2022 Aug; 50(3):196-202. PubMed ID: 35157531 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]